Del Mar, CA, United States of America

Mark D Erion

USPTO Granted Patents = 61 

 

 

Average Co-Inventor Count = 3.7

ph-index = 19

Forward Citations = 1,816(Granted Patents)

Forward Citations (Not Self Cited) = 1,638(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Del-Mar, CA (US) (1992 - 1994)
  • Livingston, NJ (US) (1991 - 1998)
  • Mountainside, NJ (US) (2017 - 2019)
  • Del Mar, CA (US) (1996 - 2021)
  • Brookline, MA (US) (2022 - 2024)

Company Filing History:


Years Active: 1991-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Thyroid Beta-Agonists
Thyromimetics
Diacylglycerol O-Acyltransferase Inhibitors
Glucokinase Activators
Factor XIa Inhibitors
Phosphorus-Containing Prodrugs
FBPase Inhibitors
Cytarabine Monophosphate Prodrugs
Fructose-1,6-Bisphosphatase Inhibitors
Adenosine Kinase Inhibitors
Liver Specific Drug Delivery
Antidiabetic Agents
61 patents (USPTO):Explore Patents

Title: The Innovative Journey of Mark D. Erion

Introduction: Mark D. Erion, based in Del Mar, California, is a renowned inventor with an impressive portfolio of 58 patents. His contributions to the field of medicine, particularly in the treatment of complex disorders, have garnered attention and respect in the scientific community.

Latest Patents: Among his latest inventions, Dr. Erion has developed innovative methods utilizing thyroid beta-agonists, specifically aimed at treating X-linked adrenoleukodystrophy. His commitment to advancing medical science is evident through these cutting-edge solutions that address critical health issues.

Career Highlights: Dr. Erion has held significant positions at leading biopharmaceutical companies, including Metabasis Therapeutics, Inc. and Gensia, Inc. His work in these organizations has been pivotal in pushing the boundaries of therapeutic development and patient care.

Collaborations: Throughout his illustrious career, Dr. Erion has collaborated with notable professionals, including K Raja Reddy and Serge H. Boyer. These partnerships have facilitated the exchange of innovative ideas and enhanced research efforts in their respective fields.

Conclusion: Mark D. Erion's extensive contributions to patenting, especially in therapeutic methods, signify his role as a key innovator in medicine. His dedication to improving healthcare solutions through his inventions will undoubtedly continue to inspire future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…